Skip to main content
. 2017 May 7;8(29):47507–47517. doi: 10.18632/oncotarget.17670

Table 4. Predictive accuracies of HCC for different cutoff values of pre-treatment WFA+-M2BP in different groups of patients.

Whole cohort (WFA+-M2BP ≥ 0.69 COI) Cirrhosis-positive (WFA+-M2BP ≥ 0.69 COI) Cirrhosis-negative (WFA+-M2BP ≥ 0.34 COI)
Sensitivity 49% 59% 83%
Specificity 84% 76% 61%
Positive-predictive value 76% 71% 68%
Negative-predictive value 62% 65% 78%

HCC, hepatocellular carcinoma; WFA+-M2BP, Wisteria floribunda agglutinin positive Mac-2 binding protein.